ACM
AlphaCrest Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,054
| Closed | -$1.55M | – | 1040 |
|
|
2022
Q3 | $1.55M | Sell |
3,054
-1,006
| -25% | -$510K | 0.09% | 340 |
|
|
2022
Q2 | $2.21M | Buy |
4,060
+2,073
| +104% | +$1.13M | 0.11% | 275 |
|
|
2022
Q1 | $1.17M | Sell |
1,987
-3,073
| -61% | -$1.82M | 0.07% | 470 |
|
|
2021
Q4 | $3.38M | Buy |
5,060
+1,894
| +60% | +$1.26M | 0.13% | 185 |
|
|
2021
Q3 | $1.81M | Sell |
3,166
-387
| -11% | -$221K | 0.09% | 355 |
|
|
2021
Q2 | $1.79M | Sell |
3,553
-13,933
| -80% | -$7.03M | 0.08% | 398 |
|
|
2021
Q1 | $7.98M | Buy |
17,486
+16,108
| +1,169% | +$7.35M | 0.44% | 27 |
|
|
2020
Q4 | $642K | Buy |
+1,378
| New | +$642K | 0.05% | 513 |
|
|
2020
Q3 | – | Sell |
-1,312
| Closed | -$475K | – | 1197 |
|
|
2020
Q2 | $475K | Sell |
1,312
-11,262
| -90% | -$4.08M | 0.08% | 410 |
|
|
2020
Q1 | $3.57M | Buy |
12,574
+4,530
| +56% | +$1.28M | 0.43% | 11 |
|
|
2019
Q4 | $2.61M | Buy |
8,044
+1,599
| +25% | +$519K | 0.21% | 79 |
|
|
2019
Q3 | $1.88M | Sell |
6,445
-697
| -10% | -$203K | 0.11% | 259 |
|
|
2019
Q2 | $2.1M | Buy |
+7,142
| New | +$2.1M | 0.18% | 143 |
|
|
2019
Q1 | – | Sell |
-5,878
| Closed | -$1.32M | – | 956 |
|
|
2018
Q4 | $1.32M | Buy |
+5,878
| New | +$1.32M | 0.39% | 32 |
|